Author:
Wörmann B.,Heyll A.,Aswald J.,Aswald S.,Staib P.,Notter M.,Lengfelder E.,Meidenbauer N.,Reichle A.,Matylis A.,Ludwig W. D.,Hiddemann W.,Büchner Th.
Publisher
Springer Berlin Heidelberg
Reference13 articles.
1. Büchner T, Hiddemann W, Wörmann B, Löffler H, Haferlach T, Gassmann W, Staib P, Heyll A, Aul C, Lengfelder E, Maschmeyer G, Ludwig W-D, Fonatsch C, Haase D, Schoch C, Sauerland C, Heinecke A: Intensified Therapy for AML: The Role of the HAM Combination. In: Acute Leukemias - Experimental Approaches and Novel Therapies. Eds: Hiddemann W, Büchner Th, Wörmann B, Ritter J, Creutzig U, Keating M, Plunkett W. Springer Verlag. Haematology and Blood Transfusion 39, 821–823, 1998
2. Mayer RJ, Davis RB, Schiffer CA et al: Intensive postremission chemotherapy in adults with acute myeloid leukemia. N. Engl. J. Med. 331: 896–903, 1994
3. Zittoun RA, Mandelli F, Willemze R, Dewitte T, Labar B, Resegotti L, Leoni F, Damasio E, Visani G, Papa G, Caronia F, Hayat M, Stryckmans P, Rotoli B, Leoni P et al.: Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. N Engl J Med 322: 217, 1995
4. Harousseau JL, Cahn JY, Pignon B, Witz F, Milipied N, Delain M et al.: Comparison of autologous bone marrow transplantation and intensive chemotherapy as postremission therapy in adult acute myeloid leukemia. Blood 90:2978, 1997
5. Burnett AK, Goldstone AH, Stevens RM, Hann IM, Rees JK, Gray RG, Wheatley K: Ramdomised comparison of addition of autologous bone marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. UK Medical Research Council Adult and Children’s Leukaemia Working Parties. Lancet 351: 700–708, 1998